Interleukin-27 is a potent inhibitor of cis HIV-1 replication in monocyte-derived dendritic cells via a type I interferon-independent pathway.
Chen, Qian; Swaminathan, Sanjay; Yang, De; Dai, Lue; Sui, Hongyan; Yang, Jun; Hornung, Ronald L; Wang, Yanmei; Huang, Da Wei; Hu, Xiaojun; Lempicki, Richard A; Imamichi, Tomozumi.
; 8(3): e59194, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23527130
Plasmacytoid dendritic cells: recent progress and open questions.
Decisions about dendritic cells: past, present, and future.
Re(de)fining the dendritic cell lineage.
IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses.
IL-17 metabolically reprograms activated fibroblastic reticular cells for proliferation and survival.
IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation.
The varieties of immunological experience: of pathogens, stress, and dendritic cells.
L-Myc expression by dendritic cells is required for optimal T-cell priming.
Nociceptive Sensory Fibers Drive Interleukin-23 Production from CD301b+ Dermal Dendritic Cells and Drive Protective Cutaneous Immunity.
IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells.